BNET Industries
Masimo is in the Health Care Industry
Latest News and Analysis
Comparison of Two New Generation Pulse Oximeters: The Masimo Radical and the Philips Viridia
"Next generation" pulse oximeters claim motion and low perfusion tolerance. In the NICU, where pulse oximetry has been useful in preventative protocols, as well as, for the detection of life-threatening oxygenation events, the combined effects of low perfusion, motion, and unpredictable interference levels still challenge some pulse oximeters' ability to...
Accuracy of Pulse Oximeters During Neonatal Motion
Most pulse oximeter manufacturers state a precision for pulse rate of ± 3 bpm and a precision for SpO2 of ± 3 % (at a bias of 0) in neonates during non-motion conditions. However, motion is common in this population. Motion adversely affects most pulse oximeters and spurious values can...
Improved Detection of Obstructive Sleep Apneas-related Hypoxemia Using Masimo SET Pulse Oximetry in Children
Children with obstructive sleep apneas often present with short apneas-hypopneas OAH and periods of partial upper airway obstruction associated with hypoxemia. The number of hypoxemic episodes and the duration of these hypoxemic periods are indicators of the severity of sleep apnea. The researchers studied the OAH detection rate of three...
Additional Resources
Masimo to Present at Lazard Capital Markets 5th Annual Healthcare Conference
IRVINE, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Masimo Corporation , the inventor of Pulse CO-OximetryTM and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that its management is scheduled to present at the Lazard Capital Markets 5th Annual Healthcare Conference at The St. Regis New York in New York,...
Masimo Reports Third Quarter 2008 Financial Results
Record results mark 21st consecutive quarter of revenue growth Q3 2008 Highlights: - Product revenues increased 29% to a record $66.0 million - Direct (Non-OEM) Business revenues increased by 48% - Shipped 30,700 new pulse oximeters and Pulse CO-Oximeters IRVINE,...
Masimo to Report Third Quarter 2008 Financial Results on October 27, 2008
Conference call and webcast to begin after markets close at 2:00 p.m. PT (5:00 p.m. ET) IRVINE, Calif., Oct. 15 /PRNewswire-FirstCall/ -- Masimo Corporation , the inventor of Pulse CO-Oximetry and Measure-Through-Motion- and-Low-Perfusion pulse oximetry, today announced it will release third quarter financial results for the period...
Masimo Announces $1 Million Performance Guarantee
Launches 'Fact vs. Fiction' website. IRVINE, Calif., Oct. 2 /PRNewswire-FirstCall/ -- Masimo Corporation , the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced a $1 million performance guarantee and unveiled a new website aimed at separating fact from fiction. The 'Fact vs. Fiction' website, http://www.nellcorfiction.com/,...
No Blood Needed Thanks to Innovative Medical Technology
SYDNEY, Australia, Sept. 26 /PRNewswire/ -- A non-invasive blood monitoring device that removes the need to draw blood to monitor patients has won the 2008 Kerrin Rennie Award for Excellence in Medical Technology. The award was presented to Masimo Corporation on 24 September at the Medical Technology Association of...
BellwetherReport.com Analyst Report on COMS, MASI, SHLD and AMSC
BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...
Examine the World Pulse Oximeters Market
Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Pulse Oximeters Market http://www.reportlinker.com/p090661/World-Pulse-Oximeters-Market.html This report analyzes the worldwide markets for Pulse Oximeters in Thousands of US$. The major types of Pulse Oximeters analyzed...
Mergent, Inc. Announces Changes to the HealthShares™ Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes
NEW YORK, May 6 /PRNewswire/ -- Mergent, Inc., administrator for the HealthsharesTM Indexes, a series of 20 underlying indexes for the HealthSharesTM Exchange Traded Funds, today announced the following changes with effect from the opening of trade on Friday, May 9, 2008: Masimo Corporation will replace Millennium Pharmaceuticals...
Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference
IRVINE, Calif., March 14 /PRNewswire-FirstCall/ -- Masimo Corporation , the inventor of Pulse CO-Oximetry and Measure-Through Motion & Low Perfusion pulse oximetry, today announced that it is scheduled to present at the Citi Investment Research 5th Annual Small & Mid-Cap Conference at The Four Seasons Hotel in Las Vegas,...
Current Review for Masimo Corporation.
M2 PRESSWIRE-27 February 2008-The SI Report: Current Review for Masimo CorporationC1994-2008 M2 COMMUNICATIONS LTD RDATE:27022008 Streetinvesting.com has now resumed our progressive review of Masimo Corporation (Nasdaq: MASI) after it traded up 7% Wednesday, early in the morning with average...
Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
Record results mark 18th consecutive quarter of revenue growth 2007 Highlights: * Product revenues increased 29% to a record $199.7 million * Masimo SET pulse oximeter units increase 20% to 116,300 units IRVINE, Calif., Feb. 26 /PRNewswire-FirstCall/ -- Masimo Corporation ,...
Masimo to Report Fourth Quarter and Fiscal Year 2007 Financial Results on February 26, 2008
Conference call and webcast with Masimo to begin at 2:00 pm PT (5:00 pm ET) IRVINE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Masimo Corporation , the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, today announced it will release fourth quarter and fiscal year...
National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM)
To: BUSINESS EDITORS Contact: Dana Banks of Masimo Corporation, +1-949-297-7348 IRVINE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Masimo (Nasdaq:MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motionand Low Perfusion pulse oximetry, announced today that the NationalFire Protection Association NFPA has included Carbon Monoxide COscreening by Pulse CO-Oximetry as part of...
Pulse CO-oximetry monitor.(PRODUCT SHOWCASE: Monitoring Systems)
[ILLUSTRATION OMITTED] In addition to the ability to provide accurate pulse oximetry (Sp[O.sub.2]) readings in situations of motion and low perfusion, the Masimo Rainbow SET Pulse CO-Oximetry platform has recently been expanded to continuously and noninvasively monitor the level of carboxyhemoglobin SpCO...
Orion HealthCorp Announces Management Changes
ATLANTA -- Orion HealthCorp, Inc. (AMEX: ONH) today announced that Ronald D. Wentling has joined the Company as Director of Business Development and William J. Suffich III will be joining the Company on October 1 as Regional Vice President. The Company also announced that Stephen H. Murdock,...
New Welch Allyn Spot-Check and Patient Monitoring Devices Feature Masimo SET Pulse Oximetry Option
Spot Vital Signs[R] and Propaq[R] LT Devices Extend Read-Through Motion SpO2 Monitoring Capabilities to More Patients in More Settings SKANEATELES FALLS, N.Y. -- Welch Allyn, a leading global manufacturer of frontline medical products and solutions, and Masimo Corporation, the inventor of Pulse CO-Oximetry and Read-Through Motion and Low...
Bedside monitor
Masimo expands its Rainbow SET Pulse CO-Oximetry platform to provide in addition to accurate pulse oximetry (SpO2) readings in situations of motion and low perfusion--also continuous and noninvasive monitoring of levels of carboxyhemoglobin SpCO and methemoglobin SpMet in the blood, allowing for quick detection and treatment of...
- Next »
- page 1 of 1
- « Previous
Sort byClose
Industry Transcripts by Seeking Alpha
-
Medical Action Industries Inc. F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 21, 2008about MDCI
-
Micrus Endovascular Corporation F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 21, 2008about MEND
-
Genomic Health, Inc. Q3 2008 Earnings Call Transcript
on Nov 20, 2008about GHDX
-
HealthSouth Corporation Q3 2008 Earnings Call Transcript
on Nov 20, 2008about HLS
-
SonoSite, Inc. Q3 2008 Earnings Call Transcript
on Nov 20, 2008about SONO